Point72 Hong Kong LTD Cyma Bay Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.72 - $3.39 $4,329 - $8,532	-2,517 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.77 - $3.64 $6,972 - $9,161	2,517 New	2,517 $8,000
Q4 2021 Feb 14, 2022	SELL	$3.23 - $4.6 $1,970 - $2,806	-610 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.47 - $4.42 $3,525 - $4,490	-1,016 Reduced 62.48%	610 $2,000
Q2 2021 Aug 16, 2021	BUY	$3.94 - $4.92 $6,406 - $7,999	1,626 New	1,626 $7,000
Q1 2021 May 17, 2021	SELL	$4.23 - $6.55 $41,741 - $64,635	-9,868 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.73 - $9.03 $56,543 - $89,108	9,868 New	9,868 $57,000
Q3 2020 Nov 16, 2020	SELL	$3.32 - $7.24 $34,534 - $75,310	-10,402 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.41 - $4.25 $13,413 - $40,430	9,513 Added 1070.08%	10,402 $36,000
Q1 2020 May 15, 2020	SELL	$1.25 - $2.02 $1,840 - $2,973	-1,472 Reduced 62.35%	889 $1,000
Q4 2019 Feb 14, 2020	BUY	$1.33 - $5.93 $2,783 - $12,411	2,093 Added 780.97%	2,361 $5,000
Q3 2019 Nov 14, 2019	BUY	$5.12 - $7.21 $1,372 - $1,932	268 New	268 $1,000
Q3 2018 Nov 14, 2018	SELL	$10.88 - $14.52 $41,724 - $55,684	-3,835 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$10.66 - $14.38 $40,881 - $55,147	3,835 New	3,835 $51,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.